Just as profound demographic changes are almost certain to have profound macroeconomic implications, I’d maintain that the ...

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...

The first step is to track down any old pensions from previous jobs, you can do this by contacting that company’s HR ...

Analyzing stochastic cell-to-cell variability can potentially reveal causal interactions in gene regulatory networks.